United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Nov 12, 2026 · Filed Nov 13, 2026

On Nov 12, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$593.52 for US$5.64M under a trading plan, leaving 324,443 shares. Filed Nov 13, 2026 (Form 4).

Sold
9,500 shares
Price
US$593.52 average (US$587.00 to US$597.33)
Value
US$5.64M
Holding after
324,443 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Nov 12, 2026Common StockOption exercise9,500US$117.76333,943Indirect
Nov 12, 2026Common StockSale159US$587.00333,784Indirect
Nov 12, 2026Common StockSale323US$588.30333,461Indirect
Nov 12, 2026Common StockSale427US$589.21333,034Indirect
Nov 12, 2026Common StockSale359US$590.11332,675Indirect
Nov 12, 2026Common StockSale317US$591.10332,358Indirect
Nov 12, 2026Common StockSale551US$592.32331,807Indirect
Nov 12, 2026Common StockSale1,934US$593.44329,873Indirect
Nov 12, 2026Common StockSale3,079US$594.24326,794Indirect
Nov 12, 2026Common StockSale1,409US$595.17325,385Indirect
Nov 12, 2026Common StockSale662US$596.22324,723Indirect
Nov 12, 2026Common StockSale280US$597.33324,443Indirect

Source

Download original · View original at SEC

Related